INTRAHEPATIC EXPRESSION OF SERUM HEPATITIS VIRUS-ASSOCIATED ANTIGENS by Edgington, Thomas S. & Ritt, Donald J.
INTRAHEPATIC  EXPRESSION  OF  SERUM  HEPATITIS 
VIRUS-ASSOCIATED ANTIGENS* 
BY THOMAS  S.  EDGINGTON, M.D.,  ANn DONALD J.  RITT, M.D. 
(From  the  Division  of  Clinical  Pathology,  Department of  Experimental  Pathology, 
Scripps  Clinic and Research Foundation; and the Division of Gastroenterology, 
Department of Medicine, University of California-San Diego, 
La Jolla, California 92037) 
(Received for publication 26 April 1971) 
It has been suggested that the same transmissible viral agent may be responsible, 
not only for parenterally transmitted long-incubation hepatitis,  but also for sporadic 
infectious hepatitis  (1, 2).  An antigen, variably described as Australia antigen (3-5), 
serum  hepatitis  (SH)  1 antigen  (6,  7),  hepatitis  antigen  (2),  or hepatitis-associated 
antigen (8), appears to be a structural component of a virus-like particle (9-11) which 
fulfills  the  requirements  for  the  serum  hepatitis  virus.  This  antigen,  or  group  of 
antigens (12-14), provides a convenient marker for SH virus particles  in blood (9-11). 
Agents such as the SH virus, because of their persistence and limited cytopathic effects 
in some individuals, possess unique pathogenetic potential beyond that of direct viral- 
induced tissue  injury.  As a  persistent  endogenous antigen  (12),  the  SH virus  may 
serve as an antigenic focus for immunologically mediated tissue injury. Alternatively, 
it may participate in the genesis  of immune complexes and the initiation of immune 
complex disease  (15,  16) in a fashion similar to that of certain persistent viral infec- 
tions in experimental animals (17,  18). 
This  study was initiated  to demonstrate  cytologic sites  and patterns  of SH 
virus-associated antigen (SH antigen)  expression in the liver.  Sites of SH viral 
synthesis in vivo have not been established; however, the presence of SH antigen 
in the nuclei of hepatocytes has been suggested by two groups of investigators 
(18-21)  using  heterologous  (13,  19,  20)  or  homologous  (21)  antisera  to  SH 
antigens. Nowoslawski, et al.  (21) have demonstrated small virus-like particles 
in the nuclei of hepatocytes from one individual and have suggested that these 
might  represent  SH virus  particles.  Because  of demonstrated  differences  be- 
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tween antisera to SH antigens (14)  and the well-recognized contribution by the 
host of cell membranes  (22)  and virus-induced membrane neoantigens  (23-25) 
to the viral coat, we have used both human and guinea pig antibody to demon- 
strate  SH  antigens  and  presumably  the  viral particles  (9)  in  tissue  and  pe- 
ripheral blood. These studies demonstrated distinct patterns of finely particulate 
SH antigen in the cytoplasm  of hepatocytes  and  other cells of the liver and in 
the peripheral blood. Neutralization studies suggest that there is more than one 
SH antigen  determinant  and  that  the  response  of the  guinea  pig is  relatively 
deficient in antibody to one of these determinants.  Two general patterns  of SH 
antigen  distribution  were  recognizable.  Whereas  hepatocyte  localization  was 
prominent  in  most,  other  cells  were  also  observed  to  contain  this  antigen  in 
some individuals.  Differences in cellular localization may represent  differences 
in host responses  to infection with the SH virus,  and  thus reflect pathogenetic 
events during  SH viral infection. 
Materials and Methods 
Liver Biopsies.--Liver specimens,  obtained by needle biopsy from 78 hospitalized patients, 2 
were included in the study. Biopsies were performed on the basis of clinical indications and 
included a  wide variety of primary and secondary hepatic diseases  with major emphasis on 
patients with acute,  recurrent,  or chronic hepatitis.  Serum specimens and peripheral blood 
smears were obtained at the time of biopsy or collection of other blood specimens. 
Preparation of Tissue.--A 5-8 mm segment of each needte biopsy core of liver was  em- 
bedded in Tissue-Tek  (Ames Laboratories,  Elkhart,  Ind.)  on a  small cork and  snap-frozen 
in liquid nitrogen. Cryostat sections were cut at 4  ~ and permitted to adhere to microscope 
slides in a humid chamber at 4°C for 16-24 hr and frozen at  --80°C for longer storage. The 
presence of SH viral particles in blood was evaluated on peripheral blood smears  dried at 
room temperature and  stored at 4°C. The remaining portion of each liver biopsy was fixed 
in  Zenker's fluid,  or  10%  formalin,  and  processed for routine histopathologic examination 
by the pathology department of each respective institution. 
Immunohistochemical  Reagents.--Fluorescein-conjugated  antibody  to  SH  antigens  (F- 
anti-SH) was prepared from the 50% saturated ammonium sulfate gamma globulin fraction 
of a potent human anti-SH by the method of Clark and Shepard  (26) using 0.12 mg fluores- 
cein isothiocyanate/mg of gamma globulin.  Nonspecific affinity for tissue was abolished by 
absorption twice with acetone-precipitated guinea pig liver powder at 25 mg/ml. The appro- 
priate  dilution  necessary  to insure  maximum  reactivity of F-anti-SH with  SH antigen in 
tissues was determined by titration on peripheral blood smears and liver biopsies,  from cases 
of well-established and  serologically positive SH virus hepatitis.  Negative peripheral blood 
smears and liver biopsies  were also included as controls. Immunologic specificity of reactions 
for SH antigens was confirmed by neutralization of F-anti-SH with an equal volume of stand- 
ard SH antigen-positive serum,  complement-fixation titer  =  512. Absorption of F-anti-SH 
with SH antigen-negative serum served as a control. Selected reactions were further confirmed 
by absorption  of F-anti-SH with SH antigen:  (a)  concentrated from serum by ultracentti- 
fugation for 18 hr at 105,000 g; (b) then subjected to sucrose density gradient ultracentrifuga- 
2 Specimens were contributed  by  University Hospital of San  Diego County,  University 
of California, San Diego; Crisis Center, County of San Diego; Scripps Clinic and  Research 
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tion;  (c) rebanding twice by isopycnic ultracentrifugation on cesium chloride gradients; and 
(d) final reisolation by ultracentrifugation in a sucrose density gradient. 3 Absorption was ex- 
pressed as the number of complement-fixing units of SH antigen per microliter of anti-SH at 
standard assay concentration. The serologic specificity of F-anti-SH was also confirmed in 
micro-Ouchterlony analysis against a panel of SH antigen-positive sera and by demonstrating 
reactions of identity with a panel of human anti-SH antisera. 
The presence and immunocytochemical localization of SH antigen in liver biopsies, periph- 
eral blood smears, and other tissues was also evaluated by indirect immunofluorescence using 
National Institutes of Health pool No. V801-501-058  of guinea pig anti-SH antigen (GP-anti- 
SH) and fluorescein-conjugated rabbit anti-guinea pig IgG (F-anti-GP "y-G). 
Fluorescein-conjugated purified antibody to human IgG, IgA, and IgM were prepared as 
previously  described  (27).  Monospecific antisera  to  human complement components Clq, 
C4,  C3,  and C54 and to fibrinogen were prepared  in goats by repeated immunization with 
highly purified antigens. Rabbit anti-guinea  pig IgG was prepared by repeated immuniza- 
tion with purified guinea pig IgG in  complete Freund's adjuvant.  5 Fluorescein-conjugated 
antibodies  were  prepared  as  previously  described  (28).  Specificity  of  immunofluorescent 
reagents was confirmed by monospecific reactions in gel double diffusion and by neutraliza- 
tion with specific antigen. 
Immunohistochemical  Reactions.--The  direct immunofluorescent reactions were performed 
on unfixed peripheral blood smears  and cryostat sections of liver. The appropriate immuno- 
fluorescent reagent was incubated on each slide for 40 min, the slides were washed three times 
in phosphate-buffered saline (PBS), and mounted in 93% glycerol, 1%  tris  (hydroxymethyl) 
aminomethane-HC1, pH 9.5. Replicate slides were reacted with positive andnegative control 
F-anti-SH. Selected specimens were reacted  with F-anti-SH absorbed with purified or semi- 
purified SH  antigen to  further confirm specificity.  Other  specificity controls included pre- 
incubation of slides with unlabeled guinea pig or human anti-SH antisera to inhibit reaction 
with F-anti-SH. 
Indirect immunofluorescence for SH antigen was performed on unfixed smears or sections 
by incubation with GP-anti-SH for  40 min, the slides were washed three times with PBS, 
and reacted with F-anti-GP "y-G for 40 min.  After three washes with PBS the slides were 
mounted in buffered glycerol as for  the direct reaction. Controls,  similar to  those for  the 
direct reaction, were also incorporated in these studies. 
Examination  of  Immunofluorescent  Slides.--Preparations  were  examined  using  a  Leitz 
Ortholux microscope fitted with a  Zeiss NA  1.2-1.4 dark-field condenser, a  Leitz HBO 200 
illuminator, a  2 mm UG-1 exciter filter, and a  K430 barrier filter. Slides were read on two 
occasions and usually with two separate anti-SH without knowledge of the clinical diagnosis 
or the presence of SH virus antigen in the serum. Results were photographically recorded on 
Anscochrome 500 color film or on Polaroid black and white film. 
Serologic Tests .for SH Antigens.--Sera from patients were tested for the presence of SFI 
antigens by double diffusion in agarose gel by a micro-Ouchterlony method including control 
positive and negative reactions in each assay (29).  Selected sera were also assayed by electro- 
immunodiffusion (30)  or complement fixation (31).  Our standard human anti-SH exhibited 
identity with anti-SH antisera from the New York Blood Center 6 and the NIH pool of guinea 
Kindly provided by Dr. Paul H. Frickey, Flow Laboratories, Rockville, Md. 
4 The highly purified complement component antigens were kindly supplied by Dr. Hans 
Mtiller-Eberhard. 
5 Kindly provided by Dr. Gary Kantor, Department of Experimental Pathology, Scripps 
Clinic and Research Foundation, La Jolla, Calif. 
6 Generously provided by Dr. Alfred Prince, New York Blood Center, New York. 874  SIt  VIRUS-ASSOCIATED ANTIGENS 
pig anti-SH. Our standard SH antigen-positive  serum reacted with all antisera and exhibited 
identity with other SH antigen-positive  sera by gel double diffusion  and had a complement- 
fixation titer of 512. 
RESULTS 
Immunochemical  Features of SH Antigenic Expressions.--SH  antigens were 
recognized by immunofluorescence in selected unfixed peripheral blood smears 
and liver biopsies using both human and guinea pig antisera to SH antigens. 
These antigens were seen in peripheral blood as numerous minute fuorescent 
green granules which usually appeared to be within the plasma (Fig. 1). Intra- 
hepatic SH antigens were expressed as fine granules in the cytoplasm of hepato- 
cytes and other intrahepatic cells (Fig. 2), but not within nuclei. Reactivity or 
integrity of SH antigens, present in peripheral blood, was abolished by exposure 
to acetone or  ethanol and  markedly attenuated by ether:ethanol (Table I). 
The integrity of these antigens in liver was significantly attenuated in a parallel 
fashion although not abolished by these solvents, thus subsequent studies were 
performed on unfixed tissues. 
Parallel titration  of human  anti-SH  and  GP-anti-SH  on peripheral  blood 
smears  from serological SH-positive and  negative individuals  indicated  con- 
cordance of these two anti-SH antisera. The blood from all serologically negative 
individuals  was  negative by immunofluorescence; and  12  of  14  serologically 
positive individuals had positive SH antigen reactions by immunofluorescence 
(Table  II).  Parallel  titration  of  both  human  anti-SH  and  GP-anti-SH  on 
selected SH antigen-positive peripheral blood smears and liver sections demon- 
strated reduced relative sensitivity for intrahepatic SH antigen as  compared 
with peripheral blood.  A  four- to eightfold greater concentration of anti-SH 
antiserum  was  required for maximum reactivity of intrahepatic  SH  antigen 
than for demonstration of peripheral blood particles,  suggesting  either steric 
masking  of intracellular  SH  antigens  by other proteins or quantitative  and 
qualitative antigenic deficiency of intracellular SH particles. 
Immunochemical specificity of the immunofluorescent reactions for SH anti- 
gens was demonstrated by competitive inhibition with anti-SH antisera and by 
neutralization with SH antigen.  Human anti-SH was  apparently more poly- 
valent than the GP-anti-SH. Nonfluoresceinated human  anti-SH,  applied to 
the SH antigen substrate in a  fourfold excess relative to the fluorescein-con- 
jugated antibody, completely blocked subsequent immunofluorescent reactions 
of both human anti-SH and GP-anti-SH (Table III). By contrast, GP-anti-SH 
in similar excess, inhibited the GP-anti-SH reaction but only partially blocked 
human anti-SH. This suggested the presence in human anti-SH of antibodies to 
antigenic determinants on SH particles that are immunochemically independent 
of, and sterically distant from, determinants recognized in common by the two 
antisera. FIG.  1.  The  immunofluorescent reactions  of human  fluorescein-conjugated anti-SH  (F- 
anti-SH)  with SH antigen particles present in peripheral blood  (1  a). The particles are ran- 
domly  scattered  in  smears,  appear  to  be  extracellular,  and  can  be  transferred  to  negative 
blood with serum. The immunofluorescent reaction is abolished by neutralizing the F  anti-SH 
with SH antigen-positive serum (1 b). X  1020. 
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Neutralization of both anti-SH antisera by SH  antigen more firmly estab- 
lished  immunochemical specificity  of  these  reactions  (Table  IV).  Immuno- 
fluorescent anti-SH reactions were consistently abolished by neutralization of 
TABLE  I 
Effects  of Organic  Solvent  Fixation  on  the  Reectivity  of SH  Antigen~ 
Liver  Peripheral blood 
Fixation  Human  Guinea pig  Human  Guinea pig 
anti-SH*  anti-SH$  anti-SH*  anti-SH~; 
None  3+  3+  4+  4+ 
Ether:ethanol (1 : 1)  3+  3+  1+  lq- 
Ethanol (95%)  1+  1H-  0  0 
Acetone  2  -4-  2  -b  0  0 
* Direct immunofluorescence  with F-anti-SH. 
:~ Indirect immunofluorescence  with GP-anti-SH followed by F-anti-GP 3'-G. 
TABLE  II 
Comparison  of Serologic and  Immunofluorescent  Methods for the Demonstration  of SH Antigen 
in Blood 
Gel double  diffusion  (serum)  Number 
Immunofluorescence* 
Positive  Negative 
Positive  14  12  2 
Negative  50  0  53 
* Direct immunofluorescence  on peripheral blood smears with human F-anti-SH. 
TABLE  III 
Competitive Inhibition  of Immunofluore~cent  A nti-SH Reactions  by A nti-SH A ntisera 
Blocking  antibody 
Reactivity of SH antigens by immunofluorescence 
Liver  Peripheral blood 
Human  Guinea pig  Human  Guinea pig 
anti-SH*  anti-SH$  anti-SH*  anti-SH$ 
None  3+  3+  4+  4+ 
Human anti-SH  0  0  0  0 
Guinea pig anti-SH  1-2+  0  2+  0 
* Direct immunofluorescence  with F-anti-SH. 
:~ Indirect immunofluorescence  with GP-anti-SH followed by F-anti-GP 3'-G. 
the  antisera  with  SH-positive  serum,  crude,  sernipurified,  and  purified  SH 
antigen. Although purified SH antigen appeared slightly less  efficient in neu- 
tralization of human F-anti-SH than in complement fixation, complete neutrali- 
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parallels the serologic difference in reactivity of these two substrates; because 
of the four- to eightfold greater reactivity of peripheral blood SH antigen, more 
complete absorption of anti-SH is necessary to neutralize this reaction. 
Character of the SII Antigen Expressions.--Typical  intrahepatic  expressions 
of SH antigen were observed as minute granular confluences within the cyto- 
plasm, but not the nucleus, of hepatocytes (Fig. 2). This was usually sparse and 
focal  (0.5-5 %  of cells),  although  in  four biopsies it  was  diffuse.  Patterns  of 
cytoplasmic localization  varied  between  individual  livers but  was  consistent 
for that individual when replicate biopsies were compared. Typical patterns of 
hepatocellular  localization  included:  (a)  diffuse  cytoplasmic,  (b)  local  cyto- 
TABLE IV 
The Capacity of Progressively Purified SH Antigen to Neutralize Anti-SH Antisera 
SH antigen concentration 
required for neutralization* 
SH antigen  Human anti-SH:~  Guinea pig anti-SH§ 
Liver  Peripheral  Liver  Peripheral 
blood  blood 
Serum  8  80  8  80 
Ultracentrifugal concentrate  8  80  8  80 
First density gradient  8  80  8  80 
Third density gradient  8  160  8  80 
Fourth density gradient  20  160  8  160 
* Expressed as complement-fixing  units of SH antigen per nficroliter of antibody. 
:~ Direct immunofluorescence with human F-anti-SH. 
§ Indirect immunofluorescence  with guinea pig anti-SH followed by F-anti-GP T-G. 
plasmic including occasional pericanalicular concentration,  and (c)  hepatocyte 
perimeter and surface (Fig. 2). 
The second generic pattern of SH antigen expression was nonhepatocellular 
(Fig.  2).  These  antigens  were  observed  as  fine  to medium-sized granules 
scattered  through  the  cytoplasm of Kupffer cells  and  sinusoidal  lining  cells. 
Granular expressions of SH antigen were also observed in cellular infiltrates at 
the periphery of lobules and within portal triads. These cells were mononuclear 
cells that could not be specifically identified but may have included histiocytes, 
mast cells, monocytes,'or even large lymphocytes. 
When intrahepatic SH antigen was correlated with clinical disease and the 
presence of SH antigen in the serum, moderate agreement between serum and 
liver SH antigen was found (Table V). Among 37 individuals with acute hepa- 
titis by history and histopathology, 46 % were positive for serum SH antigen, 
but only seven, or 41%,  of these exhibited intrahepatic SH antigen. A  similar 
proportion  of serum  SH  antigen-negative  individuals  exhibited  SH  antigens 
within the liver; however, all of these latter individuals had histories of paren- FIG.  2.  Intrahepatic  localization  of  SH  virus-associated  antigens  with  fluorescein-con- 
jugated  human anti-SH.  (a)  Focal localization of SH  antigens in  the cytoplasm of hepato- 
cytes in chronic hepatitis is seen as discrete green granules.  Other  autofluorescent material 
is seen as orange granules.  X  335.  (b)  The specific reaction seen in A  is abolished by neu- 
tralization  of F-anti-SH with purified SH  antigen.  X  335.  (c)  In  the center a  hepatocyte 
exhibits very local accumulation  of SH  antigen in  the cytoplasm  (arrow);  and in a  second 
hepatocyte  to  the  right,  pericanalicular  concentration  of  SH  antigen  is  observed.  X  335. 
(d)  Diffuse hepatocellular  distribution  of SH  antigen  is  seen in  a  case  of acute  hepatitis. 
The antigen is finely particulate and almost entirely limited to  the perimeter or surface of 
cells. X  335.  (e) Nonbepatocellular SH antigen is seen as medium-sized granules in the cyto- 
plasm of numerous mononuclear cells infiltrating a hepatocellular plate. X 155.  (f) SH antigen 
is observed in the cytoplasm of a cell along the sinusoid of a hepatic lobule (arrow). Peripheral 
blood leukocytes from this patient were negative and the positive intrahepatic cells may be 
hypertrophied sinusoidal lining cell.  X  335. 
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teral exposure. SH antigen may be detectable only when present at relatively 
high  density  and  a  negative immunofluorescence assay does not  exclude  the 
presence  of  SH  antigen  within  the  liver,  only  the  quantitative  level  of  its 
expression. 
The incidence of intrahepatic SH antigens in chronic or recurrent hepatitis 
was  similar  to the  acute  hepatitis  group,  although  a  better  correlation  with 
serum SH antigen was found (Table V). Intrahepatic SH antigen of hepatocyte 
TABLE V 
The  Incidence  and  Character  of SIt  Virus-Associated  Antigens  in  Liver  Biopsies 
Disease group 
Acute hepatitis 
Serum SH antigen positive 
Serum SH antigen negative 
Total 
Recurrent or chronic hepatitis 
Serum SH antigen positive 
Serum SH antigen  negative 
Total 
Alcoholic liver disease 
Serum SH antigen positive 
Serum SH antigen negative 
Miscellaneous 
Serum SH antigen positive 
Serum SH antigen  negative 
SH Antigen in liver* 
Non-  Both  Hepato-  hepato- 
cyte  cyte 
3  2  2 
5  1  1 
1  0 
0  2 
]  2 
1  0 




* Direct immunofluorescence  with human F-anti-SH. 
pattern was clearly demonstrated in one patient at the time of acute hepatitis 
as  well  as  3  months  later when  his  biopsy showed  chronic  active hepatitis. 
Liver biopsies from two individuals  without  recognizable hepatitis  exhibited 
intrahepatitic  SH  antigen.  The  reactions  were  quite  definite,  could  be neu- 
tralized by SH antigen, and presumably represented SH viral infection in  the 
presence of other primary hepatic disease. 
A differential intrahepatic expression of SH antigen between hepatocytes and 
nonhepatocytes  and  its  possible  significance  was  briefly  explored.  In  acute 
hepatitis more than half exhibited intrahepatic SH antigen that was limited to 
hepatocytes, whereas in recurrent or chronic hepatitis in only one case was the 
antigen  limited  to hepatocytes.  (Table V).  Most  of the  chronic  or recurrent 880  Stt  VIRUS-ASSOCIATED  ANTIGENS 
hepatitis group exhibited both hepatocellular and nonhepatocellular SH antigen. 
This differential localization is consistent with hypothetical secondary localiza- 
tion of SH antigen in nonhepatocytes. 
Intrahepatic Deposition of Immunoglobulins and Complement.--Within 21  of 
27 liver biopsies,  increased deposition of immunoglobulin and/or complement 
was demonstrable in a very limited fashion. The deposits were usually granular 
in character, frequently found along sinusoidal walls, but also observed in rare 
solitary hepatocytes and  other  scattered  cells  in  the  perilobular  and  portal 
regions. The most consistent observation was that of nucleolar deposition of 
Clq. These reactions were quite distinct and neutralized by absorption of F- 
anti-Clq with purified Clq. 16 of the 21 biopsies exhibiting nucleolar deposition 
of Clq were positive for SH antigen in the serum and/or in the liver suggesting 
a relationship between SH antigen associated hepatitis and nucleolar binding 
of Clq (Table VI). 
TABLE  VI 
Cerrdation  between Immunofluorescent  Demonstration  of Nucleolar  Clq and  Hepatitis 
Nucleolar localization of Clq 
SH antigen in serum or liver  Number 
Positive  Negative 
Positive  16  12  4 
Negative  19  2  17 
DISCUSSION 
Fluorescein-conjugated human antibody to  SH antigens binds in  a  highly 
specific fashion not only to putative SH virus particles in blood of individuals 
with serum hepatitis, but also to antigenically identical particulate material in 
the cytoplasm of hepatocytes and other cells  of the liver. Similar,  immuno- 
logically specific, reactions were observed with guinea pig anti-SH antigen. It is 
presumed  that  the  SH  antigens are viral-coat antigens induced in  host  cell 
membranes by the viral  genome and incorporated during intracellular viral 
synthesis (23-26)  and/or  during  evagination from the host  cell  (22).  Thus, 
while SH antigen in the blood might be restricted to virus particles,  certain 
viral-coded neoantigens may be induced in cells in sufficient quantity to be de- 
tected not only on the virus particle but also in the unincorporated state. The 
observation of SH antigens in cells thus implies the presence of the SH genome 
but not, of necessity, complete SH virus particles. The local intracellular distri- 
bution and particulate character of the SH antigen, observed in this study, is 
similar to that observed with many viruses. 
The use of homologous antisera for the detection of SH antigens has  the 
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stituents of the host ceils  should not be  encountered,  whereas  heterologous 
antisera to this antigen could include antibody to host-cell antigens not coded 
for by the SH genome. In spite of this hypothetical objection to heterologous 
antisera, identical reactions were observed with guinea pig anti-SH antigen. 
Levene and  Blumberg  (14)  have  observed  serologic  differences between in- 
dividual rabbit antisera to SH antigens and have demonstrated the presence of 
at least two antigenic determinants. Our results also suggest more than one SI-I 
antigen and indicate a more polyvalent antibody response to these antigens by 
our human antisera  than by guinea pig anti-SH. The disparity between our 
results and those of Millman et al. (19)  and Coyne et al. (20),  who observed 
nuclear staining with fluorescein-conjugated rabbit anti-SH, may be attribut- 
able to technical differences and/or unrecognized differences in specificity of the 
antisera to SH antigens. Technical details are significant, for acetone fixation 
as  employed by others  (19-21)  attenuates or  destroys the reactivity of SH 
antigen. Our contention that SH antigen, and by inference the virus, is present 
in the cytoplasm is supported by the observation of SH virus-like particles in 
the mitochondria of lymphoid cells infected in vitro with this agent (32).  The 
specificity of the cytoplasmic localization of SH  antigen was  established by 
neutralization studies with SH antigen-positive sera and purified SH antigen, 
as well as by competitive inhibition. The demonstrated correlation between SH 
antigen particles  in  blood  of  serologically positive  individuals by  immuno- 
fuorescence further  corroborates  identity between  SH  antigen  particles  in 
blood and similar particles in the cytoplasm of liver cells. Demonstration of SH 
antigen in blood by immunofluorescence is  indicative  of  aggregation  rather 
than distribution as solitary 160-250-A  particles (11). 
The patterns of SH antigen localization in the liver are entirely consistent 
with the focal character of hepatocellular injury and necrosis characteristic of 
SH virus  hepatitis  (33).  SH  antigens were  observed  in  hydropic as well  as 
relatively normal appearing  hepatocytes, while in  some cells  these virus-as- 
sociated antigens were observed in association with the pericanalicular region of 
hepatocytes.  The  latter  feature may be  pathogenetically related  to  the  as- 
sociated cytologic and functional abnormalities of hepatocytes and the presence 
of intracytoplasmic bile in viral hepatitis (33). The presence of SH antigens in 
the cytoplasm and in proximity to the hepatocyte surface may be pathogeneti- 
cally important in directing host immune responses to infected cells and medi- 
ating injury. Immunofluorescent studies of immunoglobulins and complement 
in liver biopsies produced some evidence for the participation of antibody and/or 
complement in the cytopathic effects associated with the hepatocellular form of 
infection and in the nonhepatocellular localization of SH antigen. The presence 
of nonhepatocellular SH antigen was usually associated with granular deposits of 
Clq in similar or identical cells. The granular deposition  of SH antigens, im- 
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Kupffer cells, and cells of the portal-perilobular  region is consistent with the 
hypothesis that these deposits may represent phagocytosed SH antigen-anti- 
body-complement complexes (31). 
The frequent presence of Clq in the nucleoli of hepatocytes in serum hepa- 
titis introduces the possibility of an  immunologic reaction, although a  similar 
deposition of immunoglobulin is not observed. Alternatively, we believe that 
these  reactions  may reflect  a  hepatitis-associated  augmentation  of  in  vitro 
binding of Clq to nucleic acids (34). The immunofluorescent reactions for Clq 
are remarkably similar to some of the reactions demonstrated by Millman et al. 
(19)  and  Coyne et  al.  (20)  for SH  antigen.  The  reactions demonstrated by 
Nowoslawski et al. are far less discrete (21). 
Intrahepatic SH antigen localization, and by analogy SH virus infection, was 
frequently rather focal in character and quantitatively limited; this contrasts 
with  peripheral  blood  where  high  concentrations  of  SFI  virus  particles  are 
frequently encountered. This dichotomy suggests that organs other than the 
liver may function as occult sites of viral synthesis; and the studies of Coyne 
et al. (20)  suggested that SH antigens might be present in tissues other than 
liver. Alternatively, the liver may be the only site of viral or SH antigen syn- 
thesis, but the sensitivity of the immunofluorescent assay may be insufficient 
to detect all cells possessing the agent and antigens. Such a  relationship has 
been  observed between the density of lymphocytic choriomeningitis (LCM) 
virus infection of cells in vitro and the number of cells exhibiting viral antigens 
by imniunofluorescence (35). 
The ability to demonstrate SH antigens in tissues may implement study of 
the immunopathogenetic events in SH virus hepatitis as well as diagnosis. The 
occurrence of chronic SH antigenemia is well recognized (12,  36)  and intra- 
hepatic persistence has been observed in this study. The presence of a replicating 
endogenous antigen introduces a pathogenetic hazard similar to that found in 
chronic LCM virus infection (17) in which potentially phlogogenic virus-anti- 
body complexes (18) may be chronically generated. Detailed immunochemical 
elucidation of the structural antigens of SH virus particles may resolve the 
disparities  observed  with  different antisera  and  may permit  discrimination 
between immune responses to: (a)  virus-specific neoantigens and (b)  host-cell 
antigens incorporated in the virus  (22-25).  Immune responses  to the former 
could mediate heteroimmune reactions to the infected host cells or lead to an 
exogenous immune complex process (37), whereas responses to the latter would 
theoretically represent  an  autologous immune complex process  (38).  In  this 
context it is significant that Gocke et al. (15) have recently suggested a patho- 
genetic role for SH  antigens in  the lesions of periarteritis  nodosa,  and pre- 
liminary  evidence  from  Nowoslawski  et  al.  (16)  supports  the  phlogogenic 
character  of immune  complexes containing SH  antigen. Alternatively, anti- 
tissue immune responses may also account for many of the pathogenetic features THOMAS S.  EDGINGTON AND DONALD J.  RITT  883 
of hepatitis.  Demonstration of persistent  intrahepatic  SH antigen in the acute 
as well  as the chronic active phase of one case of hepatitis  suggests  that  this 
agent may be directly implicated in the chronic pathogenesis. Interestingly, the 
SH  antigen  persisted  in  hepatocytes  with  prominent  surface  localization,  no 
antigenemia,  and  little  evidence  of  nonhepatocyte  localization  which  may 
implicate  cytopathic properties  or  directed  anti-tissue  host  responses  rather 
than immune complex mechanisms in this form of chronic disease. 
SUMMARY 
SH virus-associated  antigens  have been identified in the liver and blood by 
immunofluorescence.  This  antigenic  expression  of  the  hepatitis  agent  or  its 
genome is found in the cytoplasm of hepatocytes and other cells  of the liver. 
Acute hepatitis  is  associated  with  hepatocellular  localization  of SH  antigen, 
whereas alternative or additional SH antigenin the cytoplasm of nonhepatocytes 
is observed in chronic or recurrent hepatitis. Persistent intrahepatic SH antigen 
has also been observed in conversion from acute to chronic hepatitis,  and the 
persistence of this virus-associated antigen in the liver may serve a  significant 
pathogenetic role in mediating direct anti-tissue responses as well as local im- 
mune complex reactions.  Competitive inhibition studies of SH antigen suggest 
at least  two antigenically and sterically independent  determinants  on the SH 
particle. 
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